CXApp Inc (CXAI) Fair Value & Analysis
Technology · US · Market cap $27.8M
Fair value as of: Jun 24, 2026
Analysis
CXApp Inc (CXAI) currently trades at $0.2211, while our model-based Fair Value estimate is $0.3800 — implying the stock looks roughly 71.9% undervalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
About the company
CXApp Inc. provides experience solutions and delivering enterprise-grade software in the United States, Canada, and the Philippines. It offers CXAI Platform, which provides a comprehensive suite of tools to create smarter workplaces; CXAI Apps, a multi-platform suite of applications that offers personalized workflows; CXAI BTS (Behind the Scenes), a core AI engine that powers workflow automation, content management, and security compliance controls; and CXAI-VU, a generative AI analytics platform that provides actionable insights into workplace utilization, employee engagement, and operational efficiency. The company serves software/technology, financial services, next-gen auto manufacturing, entertainment, and life science companies. The company was formerly known as KINS Technology Group Inc. and changed its name to CXApp Inc. in March 2023. CXApp Inc. is headquartered in Palo Alto, California.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is CXApp Inc (CXAI) undervalued?
What is the fair value of CXAI?
What is the quality score of CXAI?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.